Ara
Treatment
The range of medical, psychological, and social services designed to help individuals reduce or stop substance use and manage substance use disorders. Treatment may include assessment, counselling and behavioural therapies, medication-assisted treatment, withdrawal management, and support for co-occurring mental or physical health conditions. Effective treatment is typically person-centred and evidence-informed, and may be provided in outpatient, community, or residential settings. Treatment aims to improve health and functioning, reduce substance-related harms, and support individuals in moving toward recovery and long-term wellbeing.
Assessment of Medical Cannabis and Health-Related Quality of Life
Abstract
Importance The use of cannabis as a medicine is becoming increasingly prevalent. Given the diverse range of conditions being treated with medical cannabis, as well as the vast array of products and dose forms available, clinical...
SMART recovery for youth: a small, exploratory qualitative study examining the potential of a mutual-aid, peer support addictive behaviour change program for young people
Abstract
Background
SMART (Self-Management and Recovery Training) Recovery is a mutual-aid program informed by cognitive behaviour therapy and motivational interviewing that provides support for a range of addictive behaviours. SMART...
Strategies to Address Cocaine and Methamphetamine
Presented by Richard Rawson, PhD, Emeritus Professor in the Department of Psychiatry and Biobehavioral Science, UCLA School of Medicine and a Research Professor at the University of Vermont, this presentation provided an overview of the...
Character Strengths and Recovery from Addiction
ISSUP Kenya present their Webinar on Insights from Positive Psychology and Psychology of Religion as applied to treatment and recovery from addiction.
UNODC supported delegations from four Central Asian countries in a high-level study tour to the United Kingdom
The UNODC Regional Office for Central Asia (ROCA) together with the UNODC Prevention, Treatment and Rehabilitation Section (PTRS) organized a study tour for high-level representatives, including senior officials, policymakers and substance...
National Drug Council equipping professionals with capacity to effectively treat substance use disorders in adolescents
Thirty adolescent treatment professionals in St. Kitts and Nevis are this week engaged in a training programme geared towards equipping them with the tools to identify, assess and treat adolescents with substance use disorders.
Buprenorphine versus methadone for the treatment of opioid dependence
Summary
Background
Opioid dependence is associated with substantial health and social burdens, and opioid agonist treatment (OAT) is highly effective in improving multiple outcomes for people who receive this treatment. Methadone and...
Economic Evaluations of Pharmacologic Treatment for Opioid Use Disorder: A Systematic Literature Review
Abstract
Objective
The crisis of opioid use puts a strain on resources in the United States and worldwide. There are 3 US Food and Drug Administration–approved medications for treatment of opioid use disorder: methadone, buprenorphine...
Focal mu-opioid receptor activation promotes neuroinflammation and microglial activation in the mesocorticolimbic system: Alterations induced by inflammatory pain
Abstract
Microglia participates in the modulation of pain signaling. The activation of microglia is suggested to play an important role in affective disorders that are related to a dysfunction of the mesocorticolimbic system (MCLS) and are...
Implementation and workflow strategies for integrating digital therapeutics for alcohol use disorders into primary care: a qualitative study
Abstract
Background
Alcohol use disorders (AUD) are prevalent and often go untreated. Patients are commonly screened for AUD in primary care, but existing treatment programs are failing to meet demand. Digital therapeutics include novel...
Buprenorphine versus methadone for the treatment of opioid dependence: a systematic review and meta-analysis of randomised and observational studies
Opioid dependence is associated with substantial health and social burdens, and opioid agonist treatment (OAT) is highly effective in improving multiple outcomes for people who receive this treatment. Methadone and buprenorphine are common...
Comparison of Treatments for Cocaine Use Disorder Among Adults
Key Points
Question What treatments for cocaine use disorder are associated with objective reductions in cocaine use among adults?
Findings In this meta-analysis of 157 clinical trials comprising 402 treatment groups and 15 842...
Cocaine Reading List
Cocaine is an addictive stimulant drug that originates from the leaves of the coca plant, which is indigenous to South America. The drug's effects include heightened alertness, attention, and energy, as well as feelings of euphoria and...
Responding to stimulant use — developments in treatment
Objective: To better understand current developments in the treatment of stimulant use.
Background: Stimulant drugs are second only to cannabis as the most widely used class of illicit drug globally, accounting for 68 million past-year...
Exploring treatment barriers on the use of crystal methamphetamine among young people in Zimbabwe
Substance misuse among young people is one of the most public concerns in global health. This study set out to explore treatment barriers among young people in Zimbabwe.
Data was collected through interviews with 30 participants
The study...
Trends in Overdose and Other Drug-Induced Deaths in Australia
This report presents the most recent and in-depth data on overdose and drug-induced deaths in Australia, covering the period 2002 to 2021. It is the most recent output in a series of annual publications on trends in drug overdose deaths...
Adolescent Substance Use and Risk Behaviours in the Mediterranean Region
Preface
The Council of Europe is the continent’s leading human rights organisation. It comprises 46 member states, 27 of which are members of the European Union. All Council of Europe member states have signed up to the European Convention...
Report: Colloquium on “Responding to the nexus between adverse childhood experiences and drug use”
A colloquium on “Responding to the Nexus between Adverse Childhood Experiences and Drug Use” was held on April 15, 2023 in New Delhi, attended by 40+ participants. The colloquium was hosted and organised by the Society for Promotion of Youth and Masses (SPYM) with the support of International Society of Substance Use Professionals (ISSUP) and Paul Hamlyn Foundation (PHF).
Ingestion of Illicit Substances by Young Children Before and During the COVID-19 Pandemic
Abstract
Importance Information about the trend in illicit substance ingestions among young children during the pandemic is limited.
Objectives To assess immediate and sustained changes in overall illicit substance ingestion rates among...
PTACC Annual Deflection Summit Call for International Presenters
Proposals are now being accepted for the 2023 Police, Treatment, and Community Collaborative’s (PTACC) National Deflection and Pre-arrest Diversion Summit.
All submissions must be uploaded by May 5, 2023 at 2:00 EDT in order to be...
